Arcus Biosciences Inc (RCUS)
17.46
-0.09
(-0.51%)
USD |
NYSE |
May 16, 16:00
17.46
0.00 (0.00%)
Pre-Market: 20:00
Arcus Biosciences Market Cap: 1.588B for May 16, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 16, 2024 | 1.588B |
| May 15, 2024 | 1.596B |
| May 14, 2024 | 1.556B |
| May 13, 2024 | 1.565B |
| May 10, 2024 | 1.520B |
| May 09, 2024 | 1.469B |
| May 08, 2024 | 1.388B |
| May 07, 2024 | 1.415B |
| May 06, 2024 | 1.451B |
| May 03, 2024 | 1.428B |
| May 02, 2024 | 1.410B |
| May 01, 2024 | 1.410B |
| April 30, 2024 | 1.385B |
| April 29, 2024 | 1.422B |
| April 26, 2024 | 1.414B |
| April 25, 2024 | 1.340B |
| April 24, 2024 | 1.403B |
| April 23, 2024 | 1.410B |
| April 22, 2024 | 1.335B |
| April 19, 2024 | 1.327B |
| April 18, 2024 | 1.350B |
| April 17, 2024 | 1.350B |
| April 16, 2024 | 1.443B |
| April 15, 2024 | 1.482B |
| April 12, 2024 | 1.508B |
| Date | Value |
|---|---|
| April 11, 2024 | 1.573B |
| April 10, 2024 | 1.522B |
| April 09, 2024 | 1.587B |
| April 08, 2024 | 1.542B |
| April 05, 2024 | 1.576B |
| April 04, 2024 | 1.569B |
| April 03, 2024 | 1.607B |
| April 02, 2024 | 1.610B |
| April 01, 2024 | 1.679B |
| March 28, 2024 | 1.716B |
| March 27, 2024 | 1.655B |
| March 26, 2024 | 1.513B |
| March 25, 2024 | 1.497B |
| March 22, 2024 | 1.493B |
| March 21, 2024 | 1.567B |
| March 20, 2024 | 1.589B |
| March 19, 2024 | 1.572B |
| March 18, 2024 | 1.565B |
| March 15, 2024 | 1.725B |
| March 14, 2024 | 1.665B |
| March 13, 2024 | 1.731B |
| March 12, 2024 | 1.694B |
| March 11, 2024 | 1.727B |
| March 08, 2024 | 1.635B |
| March 07, 2024 | 1.628B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
295.27M
Minimum
Aug 23 2019
3.405B
Maximum
Nov 23 2021
1.546B
Average
1.508B
Median
Feb 08 2023
Market Cap Benchmarks
| Gilead Sciences Inc | 84.54B |
| Catalyst Pharmaceuticals Inc | 1.937B |
| Integra Lifesciences Holdings Corp | 2.166B |
| Vertex Pharmaceuticals Inc | 113.71B |
| Adverum Biotechnologies Inc | 171.24M |
Market Cap Related Metrics
| PS Ratio | 5.695 |
| Price to Book Value | 2.246 |
| Price | 17.46 |
| Earnings Yield | -17.81% |